These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 15272539)
61. Laser capture microdissection-guided fluorescence in situ hybridization and flow cytometric cell cycle analysis of purified nuclei from paraffin sections. DiFrancesco LM; Murthy SK; Luider J; Demetrick DJ Mod Pathol; 2000 Jun; 13(6):705-11. PubMed ID: 10874675 [TBL] [Abstract][Full Text] [Related]
62. FISH detection of HER2 amplification in breast cancer. Mueller RE; O'Malley FP Methods Mol Biol; 2002; 204():353-67. PubMed ID: 12397809 [No Abstract] [Full Text] [Related]
63. Detection of c-erbB-2 (HER-2/neu) amplification in breast carcinoma by fluorescence in situ hybridization on tissue sections and imprinted cells. Kunitomo K; Takehana T; Inoue S; Fujii H; Suzuki S; Matsumoto Y; Ooi A Pathol Int; 2002 Jul; 52(7):451-7. PubMed ID: 12167103 [TBL] [Abstract][Full Text] [Related]
64. Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates. McManus DT; Patterson AH; Maxwell P; Humphreys MW; Anderson NH Mol Pathol; 1999 Apr; 52(2):75-7. PubMed ID: 10474685 [TBL] [Abstract][Full Text] [Related]
65. High-level detection of gene amplification and chromosome aneuploidy in extracted nuclei from paraffin-embedded tissue of human cancer using FISH: a new approach for retrospective studies. Rossi E; Ubiali A; Balzarini P; Cadei M; Alpi F; Grigolatoi PG Eur J Histochem; 2005; 49(1):53-8. PubMed ID: 15823795 [TBL] [Abstract][Full Text] [Related]
66. Fine-needle aspiration for nucleic acid-ased molecular analyses in breast cancer. Uzan C; Andre F; Scott V; Laurent I; Azria E; Suciu V; Balleyguier C; Lacroix L; Delaloge S; Vielh P Cancer; 2009 Feb; 117(1):32-9. PubMed ID: 19347827 [TBL] [Abstract][Full Text] [Related]
67. HER-2/neu evaluation by fluorescence in situ hybridization on destained cytologic smears from primary and metastatic breast cancer. Nizzoli R; Guazzi A; Naldi N; Fraciosi V; Bozzetti C Acta Cytol; 2005; 49(1):27-30. PubMed ID: 15717751 [TBL] [Abstract][Full Text] [Related]
68. Ubiquinol cytochrome c reductase (UQCRFS1) gene amplification in primary breast cancer core biopsy samples. Ohashi Y; Kaneko SJ; Cupples TE; Young SR Gynecol Oncol; 2004 Apr; 93(1):54-8. PubMed ID: 15047214 [TBL] [Abstract][Full Text] [Related]
69. Immunocytochemical staining of c-erb B-2 oncogene in fine-needle aspirates of breast carcinoma: a comparison with tissue sections and other breast cancer prognostic factors. Corkill ME; Katz R Diagn Cytopathol; 1994; 11(3):250-4. PubMed ID: 7867467 [TBL] [Abstract][Full Text] [Related]
70. Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Lehmann U; Glöckner S; Kleeberger W; von Wasielewski HF; Kreipe H Am J Pathol; 2000 Jun; 156(6):1855-64. PubMed ID: 10854209 [TBL] [Abstract][Full Text] [Related]
71. Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of egfr amplifications despite protein overexpression in invasive breast carcinoma. Kersting C; Tidow N; Schmidt H; Liedtke C; Neumann J; Boecker W; van Diest PJ; Brandt B; Buerger H Lab Invest; 2004 May; 84(5):582-7. PubMed ID: 15031710 [TBL] [Abstract][Full Text] [Related]
72. Demonstration of gene-amplification by PCR in archival paraffin-embedded breast cancer tissue. Lönn U; Lönn S; Nilsson B; Silfverswärd C; Stenkvist B Breast Cancer Res Treat; 1994; 30(2):147-52. PubMed ID: 7949213 [TBL] [Abstract][Full Text] [Related]
73. Chromogenic in situ hybridization in tumor pathology. Isola J; Tanner M Methods Mol Med; 2004; 97():133-44. PubMed ID: 15064490 [No Abstract] [Full Text] [Related]
74. Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma. Gancberg D; Di Leo A; Rouas G; Järvinen T; Verhest A; Isola J; Piccart MJ; Larsimont D J Clin Pathol; 2002 Apr; 55(4):315-7. PubMed ID: 11919221 [TBL] [Abstract][Full Text] [Related]
75. Immunostaining of cytology smears: a comparative study to identify the most suitable method of smear preparation and fixation with reference to commonly used immunomarkers. Shidham VB; Chang CC; Rao RN; Komorowski R; Chivukula M Diagn Cytopathol; 2003 Oct; 29(4):217-21. PubMed ID: 14506675 [TBL] [Abstract][Full Text] [Related]
76. Quantitation of erbB-2 gene copy number in breast cancer by an improved polymerase chain reaction (PCR) technique, competitively differential PCR. Deng G; Kim YS Breast Cancer Res Treat; 1999 Dec; 58(3):213-7. PubMed ID: 10718483 [TBL] [Abstract][Full Text] [Related]
77. Fraction of neoplastic cells in breast cancer samples. Correction for the oncogene amplification test. Collan Y; Haikonen J; Sundfors C Anal Quant Cytol Histol; 1999 Jun; 21(3):235-9. PubMed ID: 10560496 [TBL] [Abstract][Full Text] [Related]
78. [An improved paraffin embedding method for small core needle biopsy: technical introduction and evaluation]. Chen WL; Shi CJ; Wang M; Gu T; Tian Z Shanghai Kou Qiang Yi Xue; 2023 Feb; 32(1):6-11. PubMed ID: 36973836 [TBL] [Abstract][Full Text] [Related]
79. Fluorescence in situ hybridization of LCM-isolated nuclei from paraffin sections. Demetrick DJ; Murthy SK; DiFrancesco LM Methods Enzymol; 2002; 356():63-9. PubMed ID: 12418188 [No Abstract] [Full Text] [Related]
80. [Role of HER-2 in the treatment of breast carcinoma]. Dei Tos AP Pathologica; 2003 Oct; 95(5):278. PubMed ID: 14989022 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]